Showing results (7001-7010 of 9,818) with videos related to
Sort By:
Pageof 982
Peptides|June 15, 2019
Anxiolytic impact of Apelin-13 in a rat model of Alzheimer's disease: Involvement of glucocorticoid receptor and FKBP5Samaneh Aminyavari, Maryam Zahmatkesh, Fariba Khodagholi, et al.Peptides|March 1, 1987
Regional distribution of in vitro release of thyrotropin releasing hormone in rat brainM Mendez, P Joseph-Bravo, M Cisneros, et al.Peptides|October 31, 2021
Effects and signaling pathways of Elabela in the cardiovascular systemMeiling Zhou, Yinan WuPeptides|July 8, 2019
Intracerebroventricular administration of arginine vasotocin (AVT) induces anorexigenesis and anxiety-like behavior in goldfishKoh Araishi, Keisuke Watanabe, Takumi Yamazaki, et al.Peptides|March 1, 1985
Fronto-cortical regulation of beta-endorphin actions in the ratS Itoh, G KatsuuraPeptides|March 15, 2022
Angiotensin-(1-7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanismsOmeed Rahimi, Ana Clara Melo, Brian Westwood, et al.Peptides|December 10, 2009
Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterizationZsolt Bozso, Botond Penke, Dóra Simon, et al.Peptides|January 1, 1987
Vasoactive intestinal peptide stimulates plasminogen activator activity by cultured rat granulosa cells and cumulus-oocyte complexesY X Liu, B G Kasson, K D Dahl, et al.Peptides|May 1, 1986
Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in miceM Kavaliers, K P OssenkoppPeptides|September 1, 1986
A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29J T Turner, S B Jones, D B BylundPageof 982